A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Proceedings of the National Academy of Sciences of the United States of America
C Hirschmann-JaxM K Brenner

Abstract

A subset of stem cells, termed the "side population" (SP), has been identified in several tissues in mammalian species. These cells maintain a high efflux capability for antimitotic drugs. We have investigated whether functionally equivalent stem cells also may be detected in human cancers. We initially examined primary tumor cells from 23 patients with neuroblastoma and cell lines derived from a range of other tumors. A distinct SP was found in neuroblastoma cells from 15 of 23 patients (65%). The SP was capable of sustained expansion ex vivo and showed evidence for asymmetric division, generating both SP and non-SP progeny. These cells also expressed high levels of ABCG2 and ABCA3 transporter genes and had a greater capacity to expel cytotoxic drugs, such as mitoxantrone, resulting in better survival. A SP also was detected in breast cancer, lung cancer, and glioblastoma cell lines, suggesting that this phenotype defines a class of cancer stem cells with inherently high resistance to chemotherapeutic agents that should be targeted during the treatment of malignant disease.

References

Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L J GoldsteinM M Gottesman
Sep 25, 1989·Biochimica Et Biophysica Acta·L SvennerholmB M Rynmark
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G M BrodeurA I Freeman
Apr 1, 1996·The Journal of Experimental Medicine·M A GoodellR C Mulligan
Jan 1, 1995·Annual Review of Cell and Developmental Biology·S J MorrisonI L Weissman
Oct 1, 1995·Pathology, Research and Practice·C J KimJ G Chi
Jan 1, 1997·Trends in Genetics : TIG·H Lin, T Schagat
Mar 28, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M D NorrisM Haber
Mar 28, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M HaberM D Norris
Oct 15, 1998·Nature Medicine·J A AllayB P Sorrentino
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·K A JacksonM A Goodell
Feb 13, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·N SawaiB P Sorrentino
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·C RossigM K Brenner
Nov 2, 2001·Nature·T ReyaI L Weissman
Feb 6, 2003·International Journal of Cancer. Journal International Du Cancer·Junji TsurutaniShigeru Kohno
Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers

❮ Previous
Next ❯

Citations

Jan 1, 1984·Archives of Virology·R M LoriaV M Chinchilli
May 31, 2008·Archivum Immunologiae Et Therapiae Experimentalis·Sabine Hombach-KlonischMarek Los
Nov 29, 2011·Cancer Immunology, Immunotherapy : CII·Dongmei LaiLihe Guo
Apr 6, 2006·Pflügers Archiv : European journal of physiology·Christiane Albrecht, Enrique Viturro
May 13, 2008·Journal of Cancer Research and Clinical Oncology·Guo-Ming ShiZhi-Quan Wu
Oct 17, 2007·Cell and Tissue Research·Malcolm R AlisonSimon Leedham
Nov 8, 2007·Cell and Tissue Research·Steven Hatfield, Hannele Ruohola-Baker
Apr 19, 2011·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Naomi Pode-Shakked, Benjamin Dekel
Jun 22, 2012·Medical Molecular Morphology·Yoko MatsudaToshiyuki Ishiwata
Nov 7, 2008·Brain Tumor Pathology·Takuichiro HideToru Kondo
Jun 6, 2009·Biotechnology Letters·Tae-Bum Lee, Cheol-Hee Choi
Aug 11, 2012·Breast Cancer Research and Treatment·Rabia A GilaniAngela H Brodie
Feb 27, 2007·Cancer Metastasis Reviews·Robert W RobeySusan E Bates
Dec 17, 2009·Cancer Metastasis Reviews·William D BrandtDavid M Berman
Sep 11, 2008·Cellular and Molecular Neurobiology·Xing-gang MaoHai-ning Zhen
May 12, 2005·Journal of Mammary Gland Biology and Neoplasia·Yi Li, Jeffrey M Rosen
May 12, 2005·Journal of Mammary Gland Biology and Neoplasia·Matthew J Smalley, Robert B Clarke
Feb 19, 2009·Journal of Mammary Gland Biology and Neoplasia·Michael Dean
Jul 3, 2010·Pharmaceutical Research·Stuart IbsenSadik Esener
Aug 26, 2010·Targeted Oncology·Katrin Lamszus, Hauke S Günther
Jan 15, 2013·Targeted Oncology·Brian J MorrisonJason C Steel
Jul 3, 2008·In Vitro Cellular & Developmental Biology. Animal·Gang ShenXiaofeng Yang
May 11, 2012·Frontiers of Medicine·Douglas D FangYajun Xu
May 21, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Pérez CastilloJ Dorado
Dec 11, 2008·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José María García BuenoCarmen Ramírez-Castillejo
Aug 3, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Baoshan CaoJun Ren
Apr 12, 2008·World Journal of Pediatrics : WJP·Qiang-Song TongJia-Bin Cai
Mar 26, 2010·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jun Dou, Ning Gu
Mar 23, 2011·Cellular Oncology (Dordrecht)·Elena K SiapatiGeorge Vassilopoulos
Apr 27, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Xiao-qin ZhaoLi-Wu Fu
Jan 6, 2010·Journal of Medicinal Chemistry·Agnès I LukaszewiczMichael Kahn
Jun 29, 2013·Cell Death & Disease·J-I HanaiV P Sukhatme

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.